India Quarterly Results BSE NSE Announcements — May 14, 2026

Board Meeting Intimation for approval of the audited (Standalone & Consolidated) Financial Results for the quarter and financial year ended on 31st March, 2026.

To consider and approve the financial results for the quarter and year ended March 31, 2026 and to consider and recommend dividend, if any, on Equity Shares, for the year ended March 31, 2026.

To consider and approve the financial results for the period ended March 31, 2026

Audited Standalone & Consolidated Financial Results, Recommendation of Dividend and Revalidation of the approval obtained at 17th AGM held on July 08, 2025, for raising of funds.

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and declaration of dividend, if any.

To consider and approve the audited financial results for the period ended March 31, 2026 and consider final dividend, if any.

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

This is to inform you that a meeting of the Board of Directors of the Company is scheduled on Thursday, May 14, 2026 inter-alia to:a) consider and approve the audited standalone and consolidated financial results of the Company for the fourth quarter and year ended March 31, 2026.b) consider the recommendation of Dividend, if any, for the financial year ended March 31, 2026.Further, in continuation to our disclosure on Trading Window Closure dated March 25, 2026 pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the Trading Window for dealing in the securities of the Company shall remain closed for all the Designated Persons, their immediate relatives and connected persons of the Company till Saturday, May 16, 2026.Pursuant to Regulation 30 of SEBI Listing Regulations, we are also enclosing herewith the invitation for the earnings call with Investors/Analysts to discuss on the Company s financial and operational performance for the fourth quarter and year ended March 31, 2026 scheduled on Friday, May 15, 2026 at 16:00 hours (IST).

To consider and approve the financial results for the period ended March 31, 2026, dividend and Fund Raising

To consider and approve the financial results for the period ended March 31, 2026 and dividend

TIn terms of provisions of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of Clean Science and Technology Limited (the Company ) is scheduled to be held on Thursday, 14th May, 2026, inter alia:a) To consider and approve Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended 31st March, 2026;b) To consider recommending final dividend on the equity shares of the Company for the Financial Year ended 31st March, 2026, if any, subject to the approval of the Shareholders at the ensuing Annual General Meeting.

To consider and approve the financial results for the period ended March 31, 2026, dividend and buyback for equity shares

To consider and approve the financial results for the period ended March 31, 2026 and declare dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the Audited financial results for the quarter and financial year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the quarter & year ended March 31, 2026

To consider and approve the financial results for the quarter and year ended March 31, 2026 and recommendation of final dividend, if any subject to shareholders approval.

To consider and approve the Audited Financial Results for the quarter / year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026 and To recommend dividend if any.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and Fund Raising

To consider and approve the financial results for the period ended March 31, 2026 and final dividend, if any

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

Intimation of Meeting of Board of Directors of IndiGrid Investment Managers Limited, the Investment Manager of IndiGrid Infrastructure Trust scheduled to be held on Thursday, May 14, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, dividend and Fund Raising

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider other business matters

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve Audited Financial Results (standalone and consolidated) for the fourth quarter and financial year ended March 31, 2026 and recommendation of dividend, if any

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026

LEEL : 14-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 11, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 14, 2026, To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and recommendation of Final dividend, if any.

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

MOL : 14-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 09, 2026 has been re-scheduled and now will be held on Thursday, May 14, 2026, to consider and approve the financial results for the quarter and year ended on March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the audited financial results for the period ended March 31, 2026

To consider and approve Audited financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and recommendation of final dividend, if any

To consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and the Board may also consider the proposal for recommendation of Final Dividend on the equity shares of the Company for the Financial Year 2025-26 and fix the record date for the same.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026 and proposed Fund Raising

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend, if any

To consider and approve the Audited financial results for the period ended March 31, 2026 and other business matters

Restaurant Brands Asia Limited has informed the Exchange about Board Meeting to be held on 14-May-2026 to inter-alia consider and approve the Audited Standalone and Consolidated Financial results of the Company for the Quarter and Year ended on March 31, 2026.

To consider and approve the Audited Financial Results (Standalone & Consolidated) for the fourth quarter and year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve Audited Consolidated and Standalone Financial Results Of The Company For The Quarter And financial year Ended March 31, 2026 And To Transact Other Business Matters

Shadowfax Technologies Limited has informed the Exchange about Board Meeting to be held on 14-May-2026 to inter-alia consider and approve the Audited Financial results (Standalone & Consolidated) for the quarter and year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and final dividend

To consider and approve the unaudited financial results for the second quarter / six months ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and recommendation of dividend, if any, for the financial year ended March 31, 2026.

To consider and approve the financial results for the period ended March 31, 2026 and declaration of dividend, if any

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the quarter and year ended March 31, 2026 inter alia other business matters.

to consider and approve the audited financial results (Standalone and Consolidated) of the Company and recommend final dividend, if any, for the financial year ended 31st March 2026.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and recommendation of dividend.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the quarter and financial year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026, dividend and Fund Raising

To consider and approve the financial results for the period ended March 31, 2026 and other business matters